SPL - Starwin Products Limited
Starwin Products Limited is a pharmaceutical manufacturer based in Ghana. It traces its history to 1960 when Sterling Products International, an American pharmaceutical company, incorporated a subsidiary in Ghana. In 1976, the company sold 50% of its stock to a group of Ghanaian investors. The group eventually bought the remaining shares of the company in 1987 and subsequently changed the name to Starwin Products Limited. The company's product line includes Rapinol, Asmadrin, Painoff, Paraking, milk of magnesia and liver salts.
NOTE: Shares of Starwin Products Limited have been delisted from the Ghana Stock Exchange (GSE) since close of trading on Tuesday, January 14, 2020. Starwin Products was traded on the GSE under the ticker symbol “SPL”. Starwin Products Limited had a market capitalization of GHS 5.2 million.
|Last Trading Results|
|Day’s Low Price|
|Day’s High Price|
|Number of Deals||0|
|Growth & Valuation|
|Earnings Per Share||0.0032|
|Dividend Per Share||0.00|
SPL Stock Market Performance
The current share price of Starwin Products Limited (SPL) is GHS 0.02. SPL closed its last trading day (Monday, December 30, 2019) at 0.02 GHS per share on the Ghana Stock Exchange (GSE), recording a 33.3% drop from its previous closing price of 0.03 GHS.
Starwin Products is the 17th most traded stock on the Ghana Stock Exchange over the past three months (Oct 8, 2019 - Jan 14, 2020). SPL has traded a total volume of 14,800 shares valued at GHS 322 over the period, with an average of 12 traded shares per session. A volume high of 12,200 was achieved on December 30th for the same period. The table below details the last 10 trading days of activity of Starwin Products on the Ghana Stock Exchange.
Profile of Starwin Products Limited
Starwin Products Limited operates in the Health Care sector.
Factsheet of Starwin Products Limited
- Health Care
- P. O. Box 5760, Accra-North
SPL Industrial Market Competitors
Starwin Products Limited, issuers of the SPL stock on the Ghana Stock Exchange, have two market competitors who are also engaged in the Health Care sector. The table below presents an overview of their market standing.
|DASPHARMA||Dannex Ayrton Starwin Plc||33.9M||0.40|
|IIL||Intravenous Infusions Limited||10.4M||0.04||-20%|